Compare · ASH vs EMBCV
ASH vs EMBCV
Side-by-side comparison of Ashland Inc. (ASH) and Embecta Corp. (EMBCV): market cap, price performance, sector, and recent activity on the wire.
Summary
- ASH operates in Consumer Discretionary, while EMBCV operates in Consumer Durables - the two are in different parts of the market.
- ASH carries a market cap of $5.43B.
- ASH has hit the wire 2 times in the past 4 weeks while EMBCV has been quiet.
- ASH has more recent analyst coverage (25 ratings vs 0 for EMBCV).
- Company
- Ashland Inc.
- Embecta Corp.
- Price
- $57.41+1.02%
- $33.99-8.00%
- Market cap
- $5.43B
- -
- 1M return
- +7.07%
- -
- 1Y return
- +7.49%
- -
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 2
- 0
- Recent ratings
- 25
- 0
Ashland Inc.
Ashland Global Holdings Inc. provides specialty chemical solutions worldwide. The company's Specialty Ingredients segment offers products, technologies, and resources for solving formulation and product-performance challenges. It provides solutions using natural, synthetic, and semisynthetic polymers derived from cellulose ethers, vinyl pyrrolidones, acrylic polymers, polyester and polyurethane-based adhesives, and plant and seed extracts. This segment offers its solutions for the pharmaceutical companies; makers of personal care products, food, and beverages; makers of nutraceuticals and supplements; manufacturers of paint, coatings, and construction materials; packaging and converting markets; and oilfield service companies. Its Intermediates and Solvents produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone that are used as chemical intermediates in the production of engineering polymers and polyurethanes, as well as specialty process solvents used in electronics, pharmaceuticals, water filtration membranes, and others. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, Delaware.
Latest ASH
- Ashland sets date for second-quarter fiscal 2026 earnings release and conference call webcast
- SEC Form SCHEDULE 13G filed by Ashland Inc.
- SEC Form 4 filed by Chattopadhyay Sanat
- SEC Form 4 filed by Bishop Steven D
- Amendment: SEC Form SCHEDULE 13G/A filed by Ashland Inc.
- Ashland implements pricing actions across product portfolio in response to market volatility
- Ashland CFO to discuss current market environment at the Gabelli Funds' 17th Annual Specialty Chemicals Symposium
- Gabelli Hosts 17th Annual Specialty Chemicals Symposium
- Amendment: SEC Form SCHEDULE 13G/A filed by Ashland Inc.
- SEC Form 4 filed by Chair of the Board and CEO Novo Guillermo